↓ Skip to main content

Development of New Localized Drug Delivery System Based on Ceftriaxone-Sulbactam Composite Drug Impregnated Porous Hydroxyapatite: A Systematic Approach for In Vitro and In Vivo Animal Trial

Overview of attention for article published in Pharmaceutical Research, May 2010
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
79 Dimensions

Readers on

mendeley
108 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of New Localized Drug Delivery System Based on Ceftriaxone-Sulbactam Composite Drug Impregnated Porous Hydroxyapatite: A Systematic Approach for In Vitro and In Vivo Animal Trial
Published in
Pharmaceutical Research, May 2010
DOI 10.1007/s11095-010-0166-y
Pubmed ID
Authors

Biswanath Kundu, Chidambaram Soundrapandian, Samit K. Nandi, Prasenjit Mukherjee, Nandadulal Dandapat, Subhasis Roy, Bakul K. Datta, Tapan K. Mandal, Debabrata Basu, Rupnarayan N. Bhattacharya

Abstract

Present investigation deals with an extensive approach incorporating in vitro and in vivo experimentation to treat chronic osteomyelitis, using hydroxyapatite porous scaffolds.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 <1%
Japan 1 <1%
Denmark 1 <1%
Brazil 1 <1%
Unknown 104 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 20%
Researcher 6 6%
Student > Master 6 6%
Student > Bachelor 4 4%
Professor 4 4%
Other 14 13%
Unknown 52 48%
Readers by discipline Count As %
Materials Science 14 13%
Chemistry 8 7%
Agricultural and Biological Sciences 8 7%
Medicine and Dentistry 8 7%
Engineering 6 6%
Other 11 10%
Unknown 53 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2014.
All research outputs
#7,453,126
of 22,785,242 outputs
Outputs from Pharmaceutical Research
#1,016
of 2,856 outputs
Outputs of similar age
#34,269
of 95,067 outputs
Outputs of similar age from Pharmaceutical Research
#15
of 40 outputs
Altmetric has tracked 22,785,242 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,856 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,067 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.